10X Fund L.P. insider trades

Open-market stock purchases and sales by 10X Fund L.P., 10% Owner at Galectin Therapeutics Inc, from SEC Form 4 filings since Dec 31, 2009.

Track record: 100% of 3 scored buys are up 5% or more since purchase, averaging +238%.

Recent trades

DateStockTradeValue
Dec 16, 2025GALT Galectin Therapeutics IncSold$204K
Dec 3, 2025GALT Galectin Therapeutics IncSold$688K
Dec 3, 2025GALT Galectin Therapeutics IncSold$757K
Dec 2, 2025GALT Galectin Therapeutics IncSold$164K
Dec 2, 2025GALT Galectin Therapeutics IncSold$164K
Nov 24, 2025GALT Galectin Therapeutics IncSold (not open market)—
Nov 11, 2025GALT Galectin Therapeutics IncSold$210K

Companies traded

  • GALT Galectin Therapeutics Inc: 7 buys, 56 sales, last Dec 16, 2025
  • PRWP PRO Pharmaceuticals Inc: 8 buys, last May 10, 2010

Get free alerts when 10X Fund L.P. files a new trade →